Literature DB >> 23938864

Bone diseases. Incident fractures during treatment for osteoporosis.

Peter Vestergaard1.   

Abstract

An incident fracture sustained during treatment for osteoporosis does not necessarily represent treatment failure, an outcome that was redefined in 2012. Predictors of the new definition have now been reported and include ≥2 falls within the past year. Preventing fractures in the most at-risk patients, however, requires improved management strategies.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23938864     DOI： 10.1038/nrrheum.2013.122

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  9 in total

Review 1.  Prevention of falls and consequent injuries in elderly people.

Authors:  Pekka Kannus; Harri Sievänen; Mika Palvanen; Teppo Järvinen; Jari Parkkari
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

2.  Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis.

Authors:  C M Klotzbuecher; P D Ross; P B Landsman; T A Abbott; M Berger
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

Review 3.  Fracture prevention in postmenopausal women.

Authors:  Peter Vestergaard; Leif Mosekilde; Bente Langdahl
Journal:  BMJ Clin Evid       Date:  2011-05-03

4.  Fall and injury prevention in older people living in residential care facilities. A cluster randomized trial.

Authors:  Jane Jensen; Lillemor Lundin-Olsson; Lars Nyberg; Yngve Gustafson
Journal:  Ann Intern Med       Date:  2002-05-21       Impact factor: 25.391

Review 5.  Hip protectors for preventing hip fractures in older people.

Authors:  M J Parker; W J Gillespie; L D Gillespie
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

6.  Treatment failure in osteoporosis.

Authors:  A Diez-Perez; J D Adachi; D Agnusdei; J P Bilezikian; J E Compston; S R Cummings; R Eastell; E F Eriksen; J Gonzalez-Macias; U A Liberman; D A Wahl; E Seeman; J A Kanis; C Cooper
Journal:  Osteoporos Int       Date:  2012-07-27       Impact factor: 4.507

7.  Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Authors:  Adolfo Díez-Pérez; Jonathan D Adachi; Silvano Adami; Frederick A Anderson; Steven Boonen; Roland Chapurlat; Juliet E Compston; Cyrus Cooper; Stephen H Gehlbach; Susan L Greenspan; Frederick H Hooven; Andrea Z LaCroix; Jeri W Nieves; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Stuart Silverman; Ethel S Siris; Allison Wyman; Sophie K Rushton-Smith; Nelson B Watts
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

8.  Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Authors:  N Freemantle; C Cooper; A Diez-Perez; M Gitlin; H Radcliffe; S Shepherd; C Roux
Journal:  Osteoporos Int       Date:  2012-07-26       Impact factor: 4.507

9.  The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.

Authors:  F H Hooven; J D Adachi; S Adami; S Boonen; J Compston; C Cooper; P Delmas; A Diez-Perez; S Gehlbach; S L Greenspan; A LaCroix; R Lindsay; J C Netelenbos; J Pfeilschifter; C Roux; K G Saag; P Sambrook; S Silverman; E Siris; N B Watts; F A Anderson
Journal:  Osteoporos Int       Date:  2009-05-26       Impact factor: 4.507
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.